Michelle Ng Gong, M.D., M.S., has been officially appointed as the chair of the Montefiore Einstein Department of Medicine, affirming her leadership after serving as interim chair since May 2025. This appointment follows an extensive national search highlighting her outstanding credentials in clinical care, research, and medical education. As a professor of medicine and epidemiology & population health at Albert Einstein College of Medicine, Dr. Gong’s vision is set on elevating the department’s comprehensive clinical services and pioneering research programs to significantly impact community health outcomes.
Dr. Gong’s journey with Montefiore Einstein began in 2009 when she took the helm as director of research in the critical care division. Her trajectory demonstrated a steady expansion of influence and responsibility, notably in 2019 when she was appointed chief of critical care medicine. A year later, she strategically integrated the pulmonary medicine division under her leadership. Her tenure has been marked by a remarkable growth in research infrastructure, securing approximately $30 million in funding from federal agencies and private foundations, and achieving a fourfold increase in peer-reviewed scholarly publications—a significant indicator of both productivity and impact in medical science.
An NIH-funded principal investigator, Dr. Gong is internationally recognized for her investigative work on acute respiratory failure, sepsis, and strategies to prevent acute critical illness. Her leadership in multi-center, federally funded clinical trials has led to important findings published in premier scientific journals such as The New England Journal of Medicine and JAMA. These contributions have advanced the understanding of critical illness pathophysiology and informed novel therapeutic approaches, ultimately shaping clinical guidelines and standards of care globally.
Beyond research, Dr. Gong has been instrumental in progressive clinical service innovations. Under her guidance, Montefiore Einstein expanded its neuroscience ICU capabilities, supporting the institution’s accreditation as a comprehensive stroke center. She spearheaded quality improvement projects emphasizing patient safety and outcomes, reflecting a deep integration of evidence-based practices within clinical workflows. The introduction of cutting-edge programs such as the Robotic Bronchoscopy initiative exemplifies her commitment to integrating technological advancements into routine care, advancing the field of interventional pulmonology.
Dr. Gong’s leadership extended to significant public health efforts, notably her role in orchestrating the critical care response during the COVID-19 pandemic at Montefiore Einstein. This leadership earned her the Gotham Icon Award, a recognition of her pivotal contributions during one of modern medicine’s most challenging periods. Her ability to mobilize resources and implement efficient protocols under crisis conditions is a testament to her exceptional management skills and dedication to patient care.
In addition to her clinical and research excellence, Dr. Gong has played a crucial role in shaping respiratory health policy and advocacy. As the newly elected president of the American Thoracic Society, she represents a global community exceeding 30,000 members across 133 nations. This position enables her to influence international respiratory medicine, fostering collaboration, innovation, and dissemination of best practices aimed at reducing the burden of respiratory diseases worldwide.
Dr. Gong’s academic background is rooted in an interdisciplinary approach to medicine and engineering. She earned her Bachelor of Science in Bioengineering from the University of Pennsylvania before obtaining her medical degree from Yale University School of Medicine. Her post-graduate training includes an internal medicine residency at Beth Israel Hospital, Boston, followed by a combined clinical and research fellowship in pulmonary and critical care medicine at Harvard. Complementing her clinical training, she received a Master of Science degree in epidemiology from Harvard School of Public Health, equipping her with advanced skills in population health research methodologies.
Before her current tenure at Montefiore Einstein, Dr. Gong worked on the faculty at the Mount Sinai School of Medicine, where she developed expertise that bridged clinical care and research. Her diverse academic and clinical experiences have uniquely positioned her to lead a multispecialty department through an era of rapid scientific discovery and evolving healthcare delivery models, ultimately enhancing patient care services and academic excellence.
The Albert Einstein College of Medicine stands as a premier academic medical center dedicated to cutting-edge biomedical research, clinical investigation, and education. Located in the Bronx, the institution supports nearly 1,000 M.D., Ph.D., and M.D./Ph.D. students along with more than 2,000 full-time faculty members. With approximately $200 million in NIH funding annually, Einstein houses multiple NIH-funded research centers across fields such as cancer, diabetes, intellectual and developmental disabilities, AIDS, and translational research. Its partnership with Montefiore Health System strengthens translational efforts, ensuring that scientific discoveries swiftly translate into clinical innovations.
Montefiore Health System, encompassing 10 hospitals and over 200 outpatient care sites across New York, serves a diverse population of roughly three million individuals. It is recognized for exceptional quality and personalized healthcare, aiming to integrate clinical care, education, and research to optimize health outcomes. Its commitment to excellence spans specialty centers of excellence and community-based health initiatives, positioning it as a leader in academic medicine and a critical regional resource.
Dr. Gong’s leadership is poised to foster unprecedented growth and innovation within these interconnected institutions. Her comprehensive expertise exemplifies the future of academic medicine—where interdisciplinary research, patient-centered care, and public health converge to address complex medical challenges. As chair, she is expected to amplify Montefiore Einstein’s prominence in medical science and healthcare delivery, solidifying its mission to improve health not only in the Bronx but also on a national and global scale.
Michelle Ng Gong’s career embodies an exemplary fusion of clinical expertise, research innovation, and visionary leadership. Her accomplishments underscore the transformative power of evidence-based medicine and collaborative networks. Under her stewardship, the Montefiore Einstein Department of Medicine is set to advance scientific inquiry, elevate clinical programs, and nurture the next generation of medical leaders dedicated to combating critical illnesses and enhancing respiratory health worldwide.
Subject of Research: Acute respiratory failure, sepsis, critical illness prevention, pulmonary and critical care medicine
Article Title: Michelle Ng Gong Appointed Chair of Montefiore Einstein Department of Medicine: Pioneering Leadership in Critical Care and Respiratory Health
News Publication Date: 2025
Web References:
https://www.einsteinmed.edu/
https://www.montefiore.org/
Image Credits: Albert Einstein College of Medicine
Keywords: Critical care, pulmonary medicine, respiratory failure, sepsis, NIH-funded research, robotic bronchoscopy, stroke care, COVID-19 response, American Thoracic Society, medical leadership, epidemiology, translational research
